ELTP Stock DD Elite Pharmaceuticals, Inc. 08/04/2014 21:34:05

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
ELTP Elite Pharmaceuticals, Inc. $ELTP Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=ELTP&...mp;yt0=Go!

Last Updated: 08/04/2014 21:34:01

Current Price and Quotes
Last Price 0.355
Previous Close 0.305 Open 0.2975
Daily Range N/A - 0.359 52wk Range 0.067 - 0.97
Volume 2,788,094 Dividend N/A
Average Vol (3m) 1,426,374 Yield N/A




Financials
Period Ending Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Total Revenue 4,601 3,404 2,424 4,266
Cost of Revenue 3,236 2,315 1,014 2,675
Gross Profit 1,365 1,088 1,410 1,591
Operating Expenses

Research and Development 3,959 975 1,736 1,385
Sales, General and Admin. 2,189 1,559 1,435 918
Non-Recurring Items - - - -
Other 501 117 206 173
Operating Income (5,284) (1,563) (1,966) (886)
Income From Continuing Operations

Add'l Income/Expense Items (90,684) 3,090 (12,922) (11,507)
Earnings Before Interest and Tax (95,968) 1,527 (14,888) (12,392)
Interest Expense 900 393 654 1,491
Earnings Before Tax (96,868) 1,134 (15,542) (13,884)
Income Tax (293) (354) (484) (301)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (96,575) 1,488 (15,058) (13,582)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (96,575) 1,488 (15,058) (13,582)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (96,575) 1,488 (15,058) (13,582)

Recent News

Jul 15, 2014 Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for ELI-201
Jun 30, 2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014
Jun 26, 2014 Elite Pharmaceuticals, Inc. to Host 2014 Fiscal Year End Conference Call on Tuesday, July 1, 2014
Jun 10, 2014 Elite Pharmaceuticals Enters Into $5 Million Settlement Agreement With Novel Laboratories
Jun 9, 2014 Elite Pharmaceuticals Begins Human Abuse Liability Studies for ELI-200
May 23, 2014 Elite Pharmaceuticals Announces Results of 2014 Annual Meeting of Shareholders
May 19, 2014 Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Third Opioid Abuse Deterrent Product


ELTP Elite Pharmaceuticals, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=ELTP&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ELTP/quote
Stock Chart http://www.otcmarkets.com/stock/ELTP/chart
Company Info http://www.otcmarkets.com/stock/ELTP/company-info
Recent News http://www.otcmarkets.com/stock/ELTP/news
Financials http://www.otcmarkets.com/stock/ELTP/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ELTP/filings
Short Sales http://www.otcmarkets.com/stock/ELTP/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ELTP/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ELTP/research
Summary http://finance.yahoo.com/q?s=ELTP
Historical Prices http://finance.yahoo.com/q/hp?s=ELTP+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ELTP
Basic Chart http://finance.yahoo.com/q/bc?s=ELTP+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ELTP+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ELTP+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ELTP+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ELTP+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ELTP+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ELTP+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ELTP+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ELTP+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ELTP+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ELTP
Balance Sheet http://finance.yahoo.com/q/bs?s=ELTP
Cash Flow http://finance.yahoo.com/q/cf?s=ELTP+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ELTP
Market Watch http://www.marketwatch.com/investing/stock/ELTP
Bloomberg http://www.bloomberg.com/quote/ELTP:US
Morningstar http://quotes.morningstar.com/stock/s?t=ELTP
Bussinessweek http://investing.businessweek.com/research/st...icker=ELTP
Barchart http://www.barchart.com/quotes/stocks/ELTP
OTC Short Report http://otcshortreport.com/index.php?index=ELTP
Investopedia http://www.investopedia.com/markets/stocks/ELTP/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Market Expansion of Utility Solar Trackers: Future Insights

Updated Category News Views 247

Utility Solar Tracker Market Growth Prospects The utility solar tracker market is projected to reach an impressive USD 34.6 billion in the coming years. This growth is largely driven by the declining costs of photovoltaic (PV) panels, which have significantly lowered the financial barriers for solar energy projects. As PV panels become more affordable, the opportunity for...

Continue Reading
UVA Cancer Center Joins Caris Precision Oncology Alliance

Updated Category News Views 59

UVA Cancer Center Joins the Caris Precision Oncology Alliance UVA Cancer Center has officially joined the Caris Precision Oncology Alliance (Caris POA), a significant network dedicated to advancing precision medicine and cancer treatment. Caris Life Sciences is thrilled to welcome this esteemed institution, recognized for its commitment to enhancing patient outcomes...

Continue Reading
Investors Show Strong Confidence in Spotify Technology's Future Potential

Updated Category News Views 116

High-Rolling Investors Stake Their Bets on Spotify Technology In recent developments, it's evident that significant investors have adopted a bullish stance on Spotify Technology. This movement warrants attention from retail traders and those interested in stock market dynamics. Overview of Options Activity Tracking the latest trends, we've noted a remarkable surge in...

Continue Reading
Johnson & Johnson's Groundbreaking CAR T-Cell Therapy Data Unveiled

Updated Category News Views 191

Johnson & Johnson’s CAR T-Cell Therapy Demonstrates Promise in Lymphoma In a recent Phase 1b study, Johnson & Johnson (NYSE: JNJ) revealed the first clinical results of its investigational dual-targeting CAR T-cell therapy, JNJ-90014496, specifically aimed at treating patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). This early data suggests a...

Continue Reading
Booking Holdings Prepares for Upcoming Earnings Report

Updated Category News Views 143

Booking Holdings Set for Earnings Announcement Booking Holdings (NASDAQ: BKNG) is gearing up to share its quarterly earnings. Investors are keenly awaiting this announcement, which is expected to be significant for market sentiment and share price movements. Expected Earnings Per Share According to analysts, Booking Holdings is projected to report an impressive earnings...

Continue Reading